| dc.contributor.author | Alonso Piñero, José Ángel | |
| dc.contributor.author | González Rovira, Almudena | |
| dc.contributor.author | Sánchez Gomar, Ismael | |
| dc.contributor.author | Durán Ruiz, María del Carmen | |
| dc.contributor.other | Biomedicina, Biotecnología y Salud Pública | es_ES |
| dc.date.accessioned | 2022-07-07T10:50:48Z | |
| dc.date.available | 2022-07-07T10:50:48Z | |
| dc.date.issued | 2022-01 | |
| dc.identifier.issn | 2076-3921 | |
| dc.identifier.uri | http://hdl.handle.net/10498/27142 | |
| dc.description.abstract | Atherosclerosis remains the underlying process responsible for cardiovascular diseases and the high mortality rates associated. This chronic inflammatory disease progresses with the formation of occlusive atherosclerotic plaques over the inner walls of vascular vessels, with oxidative stress being an important element of this pathology. Oxidation of low-density lipoproteins (ox-LDL) induces endothelial dysfunction, foam cell activation, and inflammatory response, resulting in the formation of fatty streaks in the atherosclerotic wall. With this in mind, different approaches aim to reduce oxidative damage as a strategy to tackle the progression of atherosclerosis. Special attention has been paid in recent years to the transcription factor Nrf2 and its downstream-regulated protein heme oxygenase-1 (HO-1), both known to provide protection against atherosclerotic injury. In the current review, we summarize the involvement of oxidative stress in atherosclerosis, focusing on the role that these antioxidant molecules exert, as well as the potential therapeutic strategies applied to enhance their antioxidant and antiatherogenic properties. | es_ES |
| dc.format | application/pdf | es_ES |
| dc.language.iso | eng | es_ES |
| dc.publisher | MDPI | es_ES |
| dc.rights | Atribución 4.0 Internacional | * |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
| dc.source | Antioxidants, Vol. 10, Núm. 9 | es_ES |
| dc.subject | atherosclerosis | es_ES |
| dc.subject | oxidative stress | es_ES |
| dc.subject | heme oxygenase-1 | es_ES |
| dc.subject | Nrf2 | es_ES |
| dc.title | Nrf2 and Heme Oxygenase-1 Involvement in Atherosclerosis Related Oxidative Stress | es_ES |
| dc.type | journal article | es_ES |
| dc.rights.accessRights | open access | es_ES |
| dc.identifier.doi | 10.3390/ANTIOX10091463 | |
| dc.relation.projectID | info:eu-repo/grantAgreement/MINECO//PI16%2F00784/ES/Validación de biomarcadores y Terapia celular alternativa en Aterosclerosis basada en la modulación de células endoteliales progenitoras y células T reguladoras/ | es_ES |
| dc.relation.projectID | info:eu-repo/grantAgreement/ISCIII/Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016 (ISCIII)/PI17%2F00130/ES/ESTUDIO DE NUEVOS MECANISMOS Y DIANAS TERAPEUTICAS IMPLICADAS EN EL DAÑO RENAL AGUDO Y CRONICO EN PATOLOGIAS ASOCIADAS A ACUMULACION RENAL DE HEMOGLOBINA/ | es_ES |
| dc.relation.projectID | info:eu-repo/grantAgreement/ISCIII/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 (ISCIII)/PI20%2F00375/ES/NUEVOS MECANISMOS Y DIANAS TERAPEUTICAS IMPLICADAS EN LA PROGRESION DEL DAÑO RENAL EN PATOLOGIAS ASOCIADAS A ACUMULACION DE HEMOGLOBINA/ | es_ES |
| dc.relation.projectID | info:eu-repo/grantAgreement/ISCIII/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 (ISCIII)/PI20%2F00716/ES/COMPLICACIONES VASCULARES EN DIABETES MELLITUS: APLICACION DE ESTRATEGIAS PROTEOMICAS PARA POTENCIAR EL DESARROLLO DE TERAPIAS MOLECULARES%2FCELULARES ESPECIFICAS PARA CADA PACIENTE/ | es_ES |
| dc.relation.projectID | info:eu-repo/grantAgreement/MINECO//RYC-2017-22369/ES/RYC-2017-22369/ | es_ES |
| dc.relation.projectID | info:eu-repo/grantAgreement/Junta de Andalucía//PI0026-2017 | es_ES |